✦ LIBER ✦

P-457 Docetaxel/gemcitabine vs. cisplatin/gemcitabine followed bydocetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): Results of a randomised phase II trial

✍ Scribed by Binder, D.; Schweisfurth, H.; Grah, C.; Schäper, C.; Temmesfeld-Wollbrück, B.; Siebert, G.; Suttorp, N.; Beinert, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel/gemcitabine or cisplatin/gemci

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

1130 POSTER Docetaxel/gemcitabine vs. a

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Randomised multicenter phase II study of

✍ Novello, Silvia; Falcone, Alfredo; Crinò, Lucio; Rinaldi, Massimo; Nardi, Mario; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 360 KB

A phase II randomized trial of gemcitabi

✍ Joaquín Casal Rubio; S. Vázquez; F. Vázquez; M. Amenedo; J. L. Fírvida; J. R. Me 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 255 KB

A randomised phase II trial of two seque

✍ Francesco Grossi; Filippo de Marinis; Vittorio Gebbia; Ferdinando Riccardi; Oraz 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 241 KB

Phase II trial of sequential gemcitabine

✍ Foo, K.F; Leong, S.S; Ang, P; See, H.T; Ong, S; Wee, J; Fong, K.W; Machin, D; Ta 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 222 KB